Cowen lowered shares of Teladoc Health (NYSE:TDOC – Get Rating) from an outperform rating to a market perform rating in a research note released on Tuesday, MarketBeat Ratings reports. They currently have $34.00 target price on the health services provider’s stock, down from their prior target price of $58.00.
Other analysts also recently issued research reports about the company. StockNews.com upgraded Teladoc Health to a sell rating in a report on Friday, July 29th. Piper Sandler cut their price objective on Teladoc Health from $42.00 to $40.00 and set an overweight rating on the stock in a report on Thursday, July 28th. Stifel Nicolaus cut their price objective on Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th. Barclays cut their price objective on Teladoc Health from $42.00 to $40.00 and set a maintains rating on the stock in a report on Thursday, July 28th. Finally, Royal Bank of Canada cut their price objective on Teladoc Health from $215.00 to $120.00 and set an outperform rating on the stock in a report on Tuesday, April 12th. One research analyst has rated the stock with a sell rating, twenty-two have given a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has a consensus rating of Hold and an average target price of $76.10.
Teladoc Health Price Performance
Shares of Teladoc Health stock opened at $36.92 on Tuesday. The company has a current ratio of 3.94, a quick ratio of 3.71 and a debt-to-equity ratio of 0.17. The company’s 50-day moving average price is $36.22 and its two-hundred day moving average price is $52.53. Teladoc Health has a 52 week low of $27.38 and a 52 week high of $156.82. The stock has a market cap of $5.95 billion, a PE ratio of -0.60 and a beta of 0.82.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of TDOC. McCarthy Asset Management Inc. acquired a new position in Teladoc Health during the first quarter worth $25,000. DB Wealth Management Group LLC acquired a new position in Teladoc Health during the first quarter worth $25,000. City State Bank acquired a new position in Teladoc Health during the fourth quarter worth $27,000. Oliver Lagore Vanvalin Investment Group acquired a new position in Teladoc Health during the first quarter worth $27,000. Finally, CarsonAllaria Wealth Management Ltd. acquired a new position in Teladoc Health during the fourth quarter worth $30,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- AMD Q2 Earnings Beat Expectations Significantly, Is AMD A Buy?
- 3 Health Care Stocks in Great Financial Health
- Amazon Names Itself A Top Stock Of Q3 Contender
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Market Fundamentals Drive Results For The Williams Companies
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.